Weight and Body Mass Index Change After Switching to Integrase Inhibitors or Tenofovir Alafenamide Among Women Living with HIV

Weight and body mass index (BMI) change was assessed among women after switch to integrase inhibitors (INSTIs) and/or tenofovir alafenamide (TAF). From 2006 to 2019, 1,458 women living with HIV enrolled in the Women's Interagency HIV Study and on antiretroviral therapy (ART) with ≥1 study visit...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:AIDS Res Hum Retroviruses
Hoofdauteurs: Lahiri, Cecile D., Xu, Yanxun, Wang, Kunbo, Alvarez, Jessica A., Sheth, Anandi N., O'Halloran, Jane, Spence, Amanda B., Tien, Phyllis, Gustafson, Deborah R., Milam, Joel, Fischl, Margaret A., Konkle-Parker, Deborah, Adimora, Adaora A., Sharma, Anjali, Weber, Kathleen M., Ofotokun, Igho, Rubin, Leah H.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Mary Ann Liebert, Inc., publishers 2021
Onderwerpen:
Epidemiology
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8213005/
https://ncbi.nlm.nih.gov/pubmed/33231474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2020.0197
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items